GB9723780D0 - Regulation of ocular angiogenesis - Google Patents
Regulation of ocular angiogenesisInfo
- Publication number
- GB9723780D0 GB9723780D0 GB9723780A GB9723780A GB9723780D0 GB 9723780 D0 GB9723780 D0 GB 9723780D0 GB 9723780 A GB9723780 A GB 9723780A GB 9723780 A GB9723780 A GB 9723780A GB 9723780 D0 GB9723780 D0 GB 9723780D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- neovascularisation
- ocular angiogenesis
- regulation
- compounds
- retinopathy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Abstract
The invention concerns compounds that modulate Placenta Growth Factor activity and the use of such compounds for the manufacture of a medicament for treating conditions at least partially characterised by abnormal ocular angiogenesis such as retinal neovascularisation, subretinal neovascularisation, glaucomatous neovascularisation, rubeosis or corneal neovascularisation. These conditions include Vasoproliferative Retinopathy, especially Proliferative Diabetic Retinopathy.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9723780A GB9723780D0 (en) | 1997-11-12 | 1997-11-12 | Regulation of ocular angiogenesis |
AU10436/99A AU1043699A (en) | 1997-11-12 | 1998-11-12 | Regulation of ocular angiogenesis |
PCT/GB1998/003354 WO1999024056A1 (en) | 1997-11-12 | 1998-11-12 | Regulation of ocular angiogenesis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9723780A GB9723780D0 (en) | 1997-11-12 | 1997-11-12 | Regulation of ocular angiogenesis |
Publications (1)
Publication Number | Publication Date |
---|---|
GB9723780D0 true GB9723780D0 (en) | 1998-01-07 |
Family
ID=10821888
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB9723780A Ceased GB9723780D0 (en) | 1997-11-12 | 1997-11-12 | Regulation of ocular angiogenesis |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU1043699A (en) |
GB (1) | GB9723780D0 (en) |
WO (1) | WO1999024056A1 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2407858C (en) * | 2000-05-12 | 2015-10-27 | Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw | Use of inhibitors of placental growth factor for the treatment of pathological angiogenesis, pathological arteriogenesis, inflammation, tumour formation and/or vascular leakage |
WO2004046722A2 (en) | 2002-11-16 | 2004-06-03 | Dade Behring Marburg Gmbh | Scd40l, papp-a and placental growth factor (plgf) used as a biochemical marker combination in cardiovascular diseases |
NZ561763A (en) | 2005-03-24 | 2009-02-28 | Thrombogenics Nv | Novel anti PLGF antibody |
DE102005022047A1 (en) * | 2005-05-09 | 2006-11-30 | Dade Behring Marburg Gmbh | Binding partner of the placental growth factor, in particular antibodies directed against the placental growth factor, their production and use |
WO2007003609A1 (en) | 2005-06-30 | 2007-01-11 | Vib Vzw | Treatment of liver cirrhosis and its complications |
CN101534865A (en) | 2005-10-19 | 2009-09-16 | Ibc药品公司 | Methods and compositions for generating bioactive assemblies of increased complexity and uses |
MX2011003428A (en) | 2008-10-02 | 2011-07-29 | Vib Vzw | Inhibition of plgf to treat philadelphia chromosome positive leukemia. |
PL2785739T3 (en) | 2011-12-01 | 2017-10-31 | Thrombogenics Nv | Improving trabeculectomy outcome |
CA3013808A1 (en) * | 2016-03-10 | 2017-09-14 | Thrombogenics Nv | Posterior ocular fibrosis inhibition by antagonizing placental growth factor |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL117645A (en) * | 1995-03-30 | 2005-08-31 | Genentech Inc | Vascular endothelial cell growth factor antagonists for use as medicaments in the treatment of age-related macular degeneration |
CN1209068A (en) * | 1995-10-23 | 1999-02-24 | 海欧制药澳大利亚有限公司 | Hyaluronic acid as DNA carrier for gene therapy and VEGF antisense DNA to treat abnormal retinal vascularization |
ATE343400T1 (en) * | 1996-09-24 | 2006-11-15 | Merck & Co Inc | COMPOUNDS FOR INHIBITING ANGIOGENESIS BY GENE THERAPY |
-
1997
- 1997-11-12 GB GB9723780A patent/GB9723780D0/en not_active Ceased
-
1998
- 1998-11-12 WO PCT/GB1998/003354 patent/WO1999024056A1/en active Application Filing
- 1998-11-12 AU AU10436/99A patent/AU1043699A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU1043699A (en) | 1999-05-31 |
WO1999024056A1 (en) | 1999-05-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003092584A3 (en) | Agents which regulate, inhibit, or modulate the activity and/or expression of connective tissue growth factor (ctgf) as a unique means to both lower intraocular pressure and treat glaucomatous retinopathies/optic neuropathies | |
TWI255714B (en) | Method for treating meibomian gland disease | |
AU3613800A (en) | Offset ablation profiles for treatment of irregular astigmatism | |
AU3990797A (en) | Sustained release formulation | |
WO2021252538A3 (en) | Advantageous benzofuran compositions for mental disorders or enhancement | |
EP1110554A4 (en) | Medicinal compositions for treating eye diseases | |
EP0895781A3 (en) | Use of benzofurans, benzothiophenes or indoles for the manufacture of a medicament for the treatment of conditions associated with an excess of tachykinins | |
MY138811A (en) | Preventive or therapeutic agent for glaucoma | |
GB9723780D0 (en) | Regulation of ocular angiogenesis | |
EP0879601A3 (en) | Ophthalmic drug delivery system | |
DE60022683D1 (en) | NERVOUS PROTECTION PRODUCTS | |
MX9802817A (en) | Carbostyril derivative for curing ophthalmological diseases. | |
HK1045645A1 (en) | Biochemical methods that eliminate corneal scars, opacification and haze | |
HK1040182A1 (en) | Use of staurosporine derivatives for treating ocular neovascular diseases | |
AU2001267864A1 (en) | Remedial agent for optic nerve disease and the like | |
MXPA04001255A (en) | Use of compounds for treating conditions resulting from injury to the corneal nerve after lasik and other ocular surgeries or trauma. | |
AU3581695A (en) | Method and means for prevention and treatment of secondary cataract | |
IL142247A0 (en) | Method of treating sickle cell disease and thalassemia | |
MXPA05009492A (en) | Thiolactones. | |
WO2000010605A3 (en) | Preventives or remedies for eye circulatory failure | |
WO2023107653A3 (en) | Benzofuran salt morphic forms and mixtures for the treatment of mental disorders or mental enhancement | |
ES2289134T3 (en) | USE OF NON-FEMINIZING STROGENS AS PROTECTIVE AGENTS OF RETINA FOR THE TREATMENT OF GLAUCOMA. | |
WO2003020283A3 (en) | Method for treating diabetic retinopathy | |
TW362097B (en) | 3-Phenyl-1, 4-dialkyl-1,2,4-triazolium salts and their use as antidepressants |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |